“Adverse events following the first dose of ChAdOx1 nCoV-19 (COVISHIELD) vaccine in the first phase of vaccine roll out in Nepal”, J Patan Acad Health Sci, vol. 8, no. 1, pp. 9–17, Apr. 2021, doi: 10.3126/jpahs.v8i1.36242.